News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  29 January 2015  
  An oncogenic role of Agrin in regulating focal adhesion integrity in Hepatocellular carcinoma
 
 




Authors and affiliations:
Sayan Chakraborty1, Manikandan Lakshmanan1, Hannah L. F. Swa1, Jianxiang Chen1,2, Xiaoqian Zhang1, Yan Shan Ong1, Li Shen Loo1, Semih Can Akıncılar1, Jayantha Gunaratne1, Vinay Tergaonkar1, Kam M. Hui1,2 and Wanjin Hong1

1  Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), 61,    Biopolis Drive, Proteos, Singapore, 138673.
2  Laboratory of Cancer Genomics, Cellular and Molecular Research Division, National Cancer Center    Singapore, 11, Hospital Drive, Singapore 169610.

Published in Nature Communications on 29 January 2015

Abstract
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer related deaths globally. The identity and role of cell surface molecules driving complex biological events leading to HCC progression are poorly understood, hence representing major lacunae in HCC therapies. Here, combining SILAC quantitative proteomics and biochemical approaches, we uncover a critical oncogenic role of Agrin, which is overexpressed and secreted in HCC. Agrin enhances cellular proliferation, migration and oncogenic signaling. Mechanistically, Agrin’s extracellular matrix sensor activity provides oncogenic cues to regulate Arp2/3 dependant ruffling, invadopodia formation and epithelial-mesenchymal transition through sustained focal adhesion integrity that drives liver tumorigenesis. Furthermore, Agrin signaling through Lrp4-Muscle specific tyrosine kinase (MuSK) forms a critical oncogenic axis. Importantly, antibodies targeting Agrin reduced oncogenic signaling and tumor growth in vivo. Together, we demonstrate that Agrin is frequently up-regulated and important for oncogenic property of HCC and is an attractive target for antibody therapy.

Figure:

Figure Legend: A working model describing the role of Agrin in HCC. Overexpression of secreted and cell surface Agrin triggers elevated binding to its receptors Lrp4 and promotes the formation of the Agrin-Lrp4-MuSK signalling complex, which activates focal adhesions (FAK activation), Arp2/3 associated components and cortactin generating ruffling and invadopodia. This ECM sensor activity of Agrin is critical for sustaining FAK activity, cell motility, invasiveness, matrix degradation and subsequent mesenchymal marker recruitment to cell membrane. Internalized Agrin and its complex may also mediate signalling at the endosomal compartments. Cumulatively, these Agrin mediated events are essential for hepatic tumorigenesis.

For more information on Wanjin HONG 's laboratory, please click here.